Can I Import Peptides for Resale?

Whether you can import research peptides for resale depends on how the product is classified at entry, what your business entity is licensed and registered to do, and how the shipment is documented and declared — and those are questions for your customs broker and your attorney, not for any supplier's sales page. This article is informational only and is not legal advice. What can be said plainly is the operational reality: importing shifts a large amount of regulatory, financial and quality-control risk onto you as the buyer, and most businesses that price the whole thing out end up sourcing domestically instead. Real Peptides fulfills wholesale orders from within the United States through its Wholesale Partner Program, which removes the entire import variable from the equation.

All compounds discussed here are research-use-only materials. Nothing below describes human use, administration, or any downstream application, and nothing in it should be read as guidance on what your business is permitted to do — that determination is your counsel's.

What bringing a shipment across the border actually commits you to

The phrase "just order it from overseas" hides a stack of obligations that attach to whoever is named as the importer of record. That party is responsible for the accuracy of the entry filing, for the classification assigned to the goods, for the declared value, and for maintaining records that can be produced later if anyone asks. If the classification is wrong, the correction and any consequences follow the importer, not the factory that shipped it.

That entry filing is where most first-time importers underestimate the work. Goods have to be described accurately, valued accurately, and accompanied by documentation that matches what is physically in the box. A broker can prepare and transmit the filing, but a broker works from what you tell them. If your supplier's commercial invoice describes something different from the actual contents, or the packaging carries claims the paperwork doesn't support, the mismatch is yours to explain.

Then there is the possibility that a shipment is held, examined, detained, or refused entry. Any of those outcomes can happen for documentation reasons alone, independent of the quality of what's inside. When it happens, you are dealing with demurrage or storage exposure, a broker's time, a supplier several time zones away, and inventory you have already paid for that you cannot sell. Ask, before you commit: who bears the loss on a refused entry, and is that answer written into the purchase agreement or is it a verbal assurance from a sales contact?

The questions to put in front of counsel before you wire a deposit

A competent attorney can answer these for your specific entity and state far better than any article can. Bring them the list, not a summary.

• How would this specific product be classified at entry, and who is making that determination — you, your broker, or the seller?
• Who is the importer of record on this transaction, and does your entity have the registrations that role requires?
• What labeling does the product need to carry, and does the labeling on the overseas supplier's stock match what your business is permitted to sell and how you intend to describe it?
• What business licensing, resale registration, or permits does your state require for the category of goods you plan to stock, and what does your state board say when asked directly?
• What records must you retain about the shipment, the supplier, and each batch, and for how long?
• If a batch is later questioned, can you produce a chain of documentation from manufacture to your shelf?

None of these have universal answers. Requirements vary by state and by the specific nature of the goods, and they change. The durable rule is that you resolve them in writing before money moves, with counsel who has seen your actual paperwork — and that you re-confirm rather than assume the answer you got two years ago still holds.

Why an overseas certificate of analysis is not automatically a verified one

A COA is only as good as your ability to trace it. Three things separate a document that means something from a PDF that arrived attached to an email.

The first is whether the testing is batch-specific or representative. A representative COA describes a compound in general; a batch-specific COA describes the material in the container you were shipped, identified by a lot number you can match to the label in your hand. Those are not the same document and they do not carry the same weight.

The second is scope. Purity by HPLC is the number most suppliers lead with, but purity alone doesn't tell you the material is what it claims to be. Identity confirmation, and screening for the contamination markers relevant to the compound class, are separate analyses. A single purity figure with no identity work behind it is a partial picture.

The third is verifiability. Can you, without asking a salesperson, pull up the lab result for the lot you received? Some suppliers publish results openly. Others send them only on request, and a few treat COAs as a paid add-on — which is worth noticing, because a document you have to buy is a document that was optional to produce. If you import, and the paperwork can't be independently verified, the practical answer is that you retest domestically at your own cost, on your own timeline, before anything goes on your shelf. That cost is real and it lands entirely on you.

The landed cost nobody quotes in the first email

The unit price in an overseas quote is not the cost of the goods. Freight, brokerage, duties, insurance, and any handling at the port all sit on top. Then add the operational costs that don't appear on an invoice at all: capital tied up across a long lead time, storage while a shipment clears, independent retesting, and the replacement order you place when something goes wrong with the first one.

Margins across this category vary widely with volume, compound, and how you position your catalog, so no honest article can give you a range to plug into a spreadsheet. What you can do is build the model with every line item filled in — including a realistic probability that one shipment in some number of shipments doesn't arrive as planned — and compare that total against a domestic wholesale price. Buyers who run that comparison honestly often find the gap is far narrower than the headline unit price suggested, and that the remaining difference buys them a great deal of certainty.

Import route versus domestic wholesale, side by side

How domestic wholesale pricing and minimums generally work

Wholesale programs in this category are usually built on volume tiers: a lower per-unit price as order size increases, with a minimum order quantity setting the entry point. Some suppliers publish those tiers openly; others quote only after a call, which makes it impossible to model your costs before you've invested time in a sales conversation. Published pricing is a reasonable thing to insist on.

The other mechanic worth understanding is reorder cadence. A program built around infrequent large orders forces you to forecast demand months ahead and eat the cost of getting it wrong. A program with sane minimums and fast domestic fulfillment lets you reorder against what actually sold last month. For a growing catalog, that flexibility is often worth more than a small per-unit discount.

Finally, look at how the supplier handles the boring parts: batch documentation, consistency between orders, and what happens when something is wrong. Those are the things that determine whether a supplier relationship is an asset or a recurring problem.

What Real Peptides does differently

Real Peptides supplies research-use-only compounds to businesses through its Wholesale Partner Program, and the program is built around the specific gaps described above.

Compounds are produced to 99%+ HPLC purity. Every batch goes through full-panel testing covering purity, identity, and contamination markers rather than a single purity figure. The resulting certificates of analysis are publicly verifiable — a partner, or a partner's own customer, can check the lab result for a batch directly rather than requesting it, waiting for it, or paying for it. That is the difference between a supplier asking to be trusted and a supplier showing its work.

Fulfillment is domestic, with orders shipping within the United States on a stated 5–7 day window. There is no entry filing, no broker, no classification question, and no shipment sitting at a port while your customers wait. The catalog spans widely stocked research compounds — including BPC-157 and GHK-Cu — alongside the broader popular peptides collection and category-specific ranges such as growth factor and tissue signaling research compounds, so a partner can build a coherent catalog from one verified source instead of stitching together several.

Applying is a three-step process: submit the wholesale application with your business details, get reviewed and approved, then place your first order against published partner pricing.

Where that leaves a qualified buyer

If you are still weighing an import route, the honest sequence is: take the question list to your attorney, price the full landed cost with every line item included, and then compare it against a domestic wholesale quote with verifiable batch testing behind it. If the domestic number holds up — and for most businesses building a catalog rather than running a container operation, it does — the import question resolves itself. Businesses ready to move can submit an application to the Wholesale Partner Program and be reviewed for partner pricing.

Further reading on partner terms and onboarding is available through the wholesale peptides program overview, and qualified businesses can apply for a wholesale account directly.